The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perkel, J. M.
Right arrow Articles by Atchison, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perkel, J. M.
Right arrow Articles by Atchison, M. L.
The Journal of Immunology, 1998, 160: 241-252.
Copyright © 1998 by The American Association of Immunologists

A Two-Step Mechanism for Recruitment of Pip by PU.11

Jeffrey M. Perkel* and Michael L. Atchison2,*,{dagger}

* Graduate Group of Molecular Biology and {dagger} Laboratories of Biochemistry, Department of Animal Biology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104

Transcription of the Ig {kappa} light chain gene is controlled in part by the 3' {kappa} enhancer. Two of the proteins that bind to the 3' enhancer, PU.1 and Pip, show tissue-restricted expression and may be responsible for the tissue specificity of 3' enhancer activity. PU.1 alone can bind to DNA; however, Pip cannot bind to its 3' enhancer site in electrophoretic mobility shift assays, unless recruited by PU.1. Previously, we showed that the PU.1 PEST domain (rich in the amino acids proline, glutamate, serine, and threonine; sequences 118–160) is necessary for Pip recruitment to DNA. Here we used detailed mutagenic analyzes of PU.1 to more precisely identify sequences required for Pip recruitment by electrophoretic mobility shift assay. We found that mutation of three segments within the PU.1 PEST domain (118–125, 133–139, and 141–147) modulated the efficiency of Pip recruitment, while mutation of sequences between residues 88–118 and 154–168 had no effect. Interestingly, we found that the PU.1 ETS domain (residues 170 to 255) is both necessary and sufficient for Pip interaction in solution and that other ETS domain proteins can physically interact with Pip as well. Our results suggest that Pip recruitment to DNA by PU.1 occurs via a two-step mechanism. First, a physical interaction that is not sufficient to recruit Pip occurs via the PU.1 ETS domain. Second, a conformational change in the PU.1 PEST domain, apparently mediated by serine phosphorylation, induces a conformational change in Pip enabling it to bind to DNA. We also show that the PU.1 PEST domain does not target PU.1 for rapid turnover.




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
F. Wei, K. Zaprazna, J. Wang, and M. L. Atchison
PU.1 Can Recruit BCL6 to DNA To Repress Gene Expression in Germinal Center B Cells
Mol. Cell. Biol., September 1, 2009; 29(17): 4612 - 4622.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. C. Azim, X. Wang, G. Y. Park, R. T. Sadikot, H. Cao, B. Mathew, M. Atchison, R. B. van Breemen, M. Joo, and J. W. Christman
NF-{kappa}B-Inducing Kinase Regulates Cyclooxygenase 2 Gene Expression in Macrophages by Phosphorylation of PU.1
J. Immunol., December 1, 2007; 179(11): 7868 - 7875.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Dahl, S. R. Iyer, K. S. Owens, D. D. Cuylear, and M. C. Simon
The Transcriptional Repressor GFI-1 Antagonizes PU.1 Activity through Protein-Protein Interaction
J. Biol. Chem., March 2, 2007; 282(9): 6473 - 6483.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Hodawadekar, F. Wei, D. Yu, A. Thomas-Tikhonenko, and M. L. Atchison
Epigenetic Histone Modifications Do Not Control Ig{kappa} Locus Contraction and Intranuclear Localization in Cells with Dual B Cell-Macrophage Potential
J. Immunol., November 1, 2006; 177(9): 6165 - 6171.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Guillouf, I. Gallais, and F. Moreau-Gachelin
Spi-1/PU.1 Oncoprotein Affects Splicing Decisions in a Promoter Binding-dependent Manner
J. Biol. Chem., July 14, 2006; 281(28): 19145 - 19155.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Wang, R. M. Baron, G. Zhu, M. Joo, J. W. Christman, E. S. Silverman, M. A. Perrella, R. J. Riese, and M. Cernadas
PU.1 Regulates Cathepsin S Expression in Professional APCs
J. Immunol., January 1, 2006; 176(1): 275 - 283.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Lehtonen, V. Veckman, T. Nikula, R. Lahesmaa, L. Kinnunen, S. Matikainen, and I. Julkunen
Differential Expression of IFN Regulatory Factor 4 Gene in Human Monocyte-Derived Dendritic Cells and Macrophages
J. Immunol., November 15, 2005; 175(10): 6570 - 6579.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Bai, L. Srinivasan, L. Perkins, and M. L. Atchison
Protein Acetylation Regulates Both PU.1 Transactivation and Ig{kappa} 3' Enhancer Activity
J. Immunol., October 15, 2005; 175(8): 5160 - 5169.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Laricchia-Robbio, T. Tamura, T. Karpova, B. L. Sprague, J. G. McNally, and K. Ozato
Partner-regulated interaction of IFN regulatory factor 8 with chromatin visualized in live macrophages
PNAS, October 4, 2005; 102(40): 14368 - 14373.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. V. Pedchenko, G. Y. Park, M. Joo, T. S. Blackwell, and J. W. Christman
Inducible binding of PU.1 and interacting proteins to the Toll-like receptor 4 promoter during endotoxemia
Am J Physiol Lung Cell Mol Physiol, September 1, 2005; 289(3): L429 - L437.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. C. McDevit, L. Perkins, M. L. Atchison, and B. S. Nikolajczyk
The Ig{kappa}3' Enhancer Is Activated by Gradients of Chromatin Accessibility and Protein Association
J. Immunol., March 1, 2005; 174(5): 2834 - 2842.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. van der Stoep, E. Quinten, M. M. Rezende, and P. J. van den Elsen
E47, IRF-4, and PU.1 synergize to induce B-cell-specific activation of the class II transactivator promoter III (CIITA-PIII)
Blood, November 1, 2004; 104(9): 2849 - 2857.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Suzuki, K. Honma, T. Matsuyama, K. Suzuki, K. Toriyama, I. Akitoyo, K. Yamamoto, T. Suematsu, M. Nakamura, K. Yui, et al.
From the Cover: Critical roles of interferon regulatory factor 4 in CD11bhighCD8{alpha}- dendritic cell development
PNAS, June 15, 2004; 101(24): 8981 - 8986.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Hines, B. R. Sorensen, M. A. Shea, and W. Maury
PU.1 Binding to ets Motifs within the Equine Infectious Anemia Virus Long Terminal Repeat (LTR) Enhancer: Regulation of LTR Activity and Virus Replication in Macrophages
J. Virol., April 1, 2004; 78(7): 3407 - 3418.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Alter-Koltunoff, S. Ehrlich, N. Dror, A. Azriel, M. Eilers, H. Hauser, H. Bowen, C. H. Barton, T. Tamura, K. Ozato, et al.
Nramp1-mediated Innate Resistance to Intraphagosomal Pathogens Is Regulated by IRF-8, PU.1, and Miz-1
J. Biol. Chem., November 7, 2003; 278(45): 44025 - 44032.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. Hashmueli, M. Gleit-Kielmanowicz, D. Meraro, A. Azriel, D. Melamed, and B.-Z. Levi
A truncated IFN-regulatory factor-8\IFN consensus sequence-binding protein acts as dominant-negative, interferes with endogenous protein-protein interactions and leads to apoptosis of immune cells
Int. Immunol., July 1, 2003; 15(7): 807 - 815.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. O'Reilly, C. M. Quinn, T. El-Shanawany, S. Gordon, and D. R. Greaves
Multiple Ets Factors and Interferon Regulatory Factor-4 Modulate CD68 Expression in a Cell Type-specific Manner
J. Biol. Chem., June 6, 2003; 278(24): 21909 - 21919.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. R. McKercher, C. R. Lombardo, A. Bobkov, X. Jia, and N. Assa-Munt
Identification of a PU.1-IRF4 protein interaction surface predicted by chemical exchange line broadening
PNAS, January 21, 2003; 100(2): 511 - 516.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Kuwata, C. Gongora, Y. Kanno, K. Sakaguchi, T. Tamura, T. Kanno, V. Basrur, R. Martinez, E. Appella, T. Golub, et al.
Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element
Mol. Cell. Biol., November 1, 2002; 22(21): 7439 - 7448.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Meraro, M. Gleit-Kielmanowicz, H. Hauser, and B.-Z. Levi
IFN-Stimulated Gene 15 Is Synergistically Activated Through Interactions Between the Myelocyte/Lymphocyte-Specific Transcription Factors, PU.1, IFN Regulatory Factor-8/IFN Consensus Sequence Binding Protein, and IFN Regulatory Factor-4: Characterization of a New Subtype of IFN-Stimulated Response Element
J. Immunol., June 15, 2002; 168(12): 6224 - 6231.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W. Hong, A. Y. Kim, S. Ky, C. Rakowski, S.-B. Seo, D. Chakravarti, M. Atchison, and G. A. Blobel
Inhibition of CBP-Mediated Protein Acetylation by the Ets Family Oncoprotein PU.1
Mol. Cell. Biol., June 1, 2002; 22(11): 3729 - 3743.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Kim and R. A. Feldman
Activated Fes Protein Tyrosine Kinase Induces Terminal Macrophage Differentiation of Myeloid Progenitors (U937 Cells) and Activation of the Transcription Factor PU.1
Mol. Cell. Biol., March 15, 2002; 22(6): 1903 - 1918.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Marecki, C. J. Riendeau, M. D. Liang, and M. J. Fenton
PU.1 and Multiple IFN Regulatory Factor Proteins Synergize to Mediate Transcriptional Activation of the Human IL-1{{beta}} Gene
J. Immunol., June 1, 2001; 166(11): 6829 - 6838.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Gupta, A. Anthony, and A. B. Pernis
Stage-Specific Modulation of IFN-Regulatory Factor 4 Function by Kruppel-Type Zinc Finger Proteins
J. Immunol., May 15, 2001; 166(10): 6104 - 6111.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B. Lubyova and P. M. Pitha
Characterization of a Novel Human Herpesvirus 8-Encoded Protein, vIRF-3, That Shows Homology to Viral and Cellular Interferon Regulatory Factors
J. Virol., September 1, 2000; 74(17): 8194 - 8201.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
S. Maitra and M. Atchison
BSAP Can Repress Enhancer Activity by Targeting PU.1 Function
Mol. Cell. Biol., March 15, 2000; 20(6): 1911 - 1922.
[Abstract] [Full Text]


Home page
BloodHome page
B. Falini, M. Fizzotti, A. Pucciarini, B. Bigerna, T. Marafioti, M. Gambacorta, R. Pacini, C. Alunni, L. Natali-Tanci, B. Ugolini, et al.
A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells
Blood, March 15, 2000; 95(6): 2084 - 2092.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Meraro, S. Hashmueli, B. Koren, A. Azriel, A. Oumard, S. Kirchhoff, H. Hauser, S. Nagulapalli, M. L. Atchison, and B.-Z. Levi
Protein-Protein and DNA-Protein Interactions Affect the Activity of Lymphoid-Specific IFN Regulatory Factors
J. Immunol., December 15, 1999; 163(12): 6468 - 6478.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Marecki, M. L. Atchison, and M. J. Fenton
Differential Expression and Distinct Functions of IFN Regulatory Factor 4 and IFN Consensus Sequence Binding Protein in Macrophages
J. Immunol., September 1, 1999; 163(5): 2713 - 2722.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Cohen, A. Azriel, T. Cohen, D. Meraro, S. Hashmueli, D. Bech-Otschir, R. Kraft, W. Dubiel, and B.-Z. Levi
Interaction between Interferon Consensus Sequence-binding Protein and COP9/Signalosome Subunit CSN2 (Trip15). A POSSIBLE LINK BETWEEN INTERFERON REGULATORY FACTOR SIGNALING AND THE COP9/SIGNALOSOME
J. Biol. Chem., December 8, 2000; 275(50): 39081 - 39089.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Rieske and J. M. R. Pongubala
AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain
J. Biol. Chem., March 9, 2001; 276(11): 8460 - 8468.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Luchin, S. Suchting, T. Merson, T. J. Rosol, D. A. Hume, A. I. Cassady, and M. C. Ostrowski
Genetic and Physical Interactions between Microphthalmia Transcription Factor and PU.1 Are Necessary for Osteoclast Gene Expression and Differentiation
J. Biol. Chem., September 21, 2001; 276(39): 36703 - 36710.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.